卡魯梅特公司
US ˙ NasdaqGS ˙ US1314761032

SecurityCLMT / Calumet, Inc.
InstitutionMorgan Stanley
Latest Disclosed Ownership1,051,997 shares
Latest Disclosed Value $ 37,766,692
Morgan Stanley reports 5.90% decrease in ownership of CLMT / Calumet, Inc.

On May 15, 2026 - Morgan Stanley filed a 13F-HR form disclosing ownership of 1,051,997 shares of Calumet, Inc. (US:CLMT) valued at $37,766,692 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on May 27, 2026 disclosing 1,117,977 shares of Calumet, Inc.. This represents a change in shares of -5.90% during the quarter. The current value of the position is $39,355,208 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F CALUMET COM 131428104 1,051,997 -65,980 -5.90 37,767 70.01 0.0023
2026-05-27 2025-12-31 13F/A-1 CALUMET COM 131428104 1,117,977 329,750 41.83 22,214 54.42 0.0013
2026-02-13 2025-12-31 13F CALUMET COM 131428104 1,117,977 329,750 22,214 0.0013
2026-05-27 2025-09-30 13F/A-1 CALUMET COM 131428104 788,227 276,584 54.06 14,385 78.47 0.0009
2025-11-14 2025-09-30 13F CALUMET COM 131428104 788,227 276,584 14,385 0.0009
2025-08-15 2025-06-30 13F CALUMET COM 131428104 511,643 -291,202 -36.27 8,061 -20.83 0.0005
2025-05-15 2025-03-31 13F CALUMET COM 131428104 802,845 -736,040 -47.83 10,180 -69.96 0.0007
2025-05-15 2024-12-31 13F/A-1 CALUMET COM 131428104 1,538,885 1,287,065 511.11 33,886 655.20 0.0024
2025-02-14 2024-12-31 13F CALUMET COM 131428104 1,538,885 1,287,065 33,886 0.0024
2025-05-14 2024-09-30 13F/A-2 CALUMET COM 131428104 251,820 251,820 4,487 0.0003
2025-02-14 2024-09-30 13F/A-1 CALUMET COM 131428104 251,820 251,820 4,487 0.0000
2024-11-14 2024-09-30 13F CALUMET COM 131428104 251,820 251,820 4,487 0.0003
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.